Visualizing T cell migration in vivo

International Archives of Allergy and Immunology

Volumn 132, Issue 4, 2003, Pages 277-293

  Iparraguirre, Amaya ^a   Weninger, Wolfgang ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b WISTAR INSTITUTE   (United States)

Author keywords

Adhesion molecules; Chemokines; Lymphocytes; Microscopy; Trafficking

Indexed keywords

ADDRESSIN; ANTIGEN; BETA2 INTEGRIN; CD11 ANTIGEN; CD18 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCR8; CHEMOKINE RECEPTOR CCR9; CHEMOKINE RECEPTOR CXCR4; GREEN FLUORESCENT PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; HEMOGLOBIN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; LIGAND; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOCLONAL ANTIBODY; PERTUSSIS TOXIN; PODOCALYXIN; RHODAMINE 6G; SELECTIN; T LYMPHOCYTE RECEPTOR; UNINDEXED DRUG;

ANTIGEN PRESENTING CELL; BIOLUMINESCENCE; CELL INTERACTION; CELL LEVEL; CELL POPULATION; CIRCULATION; CYTOKINE PRODUCTION; HUMAN; IMAGING; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IN VIVO STUDY; LYMPH NODE; LYMPHOCYTE HOMING; LYMPHOCYTE MIGRATION; LYMPHOID CELL; LYMPHOID ORGAN; MEMORY CELL; MESENTERY LYMPH NODE; MICROSCOPY; NATURAL KILLER CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTON; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPLEEN; T LYMPHOCYTE; TISSUE SECTION;

ANIMALS; CELL MOVEMENT; IMMUNOLOGIC TECHNIQUES; LUMINESCENT MEASUREMENTS; MAGNETIC RESONANCE IMAGING; MICE; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE, MULTIPHOTON; T-LYMPHOCYTES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0347950055     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000074896     Document Type: Review

References (159)

1. Butcher EC, Picker LJ: Lymphocyte homing and homeostasis. Science 1996;272:60-66.
2. von Andrian UH, Mackay CR: T-cell function and migration. Two sides of the same coin. N Engl J Med 2000;343:1020-1034.
3. Lanzavecchia A, Sallusto F: The instructive role of dendritic cells on T-cell responses: Lineages, plasticity and kinetics. Curr Opin Immunol 2001;13:291-298.
4. Randolph GJ: Dendritic cell migration to lymph nodes: Cytokines, chemokines and lipid mediators. Semin Immunol 2001;13:267-274.
5. Cavanagh LL, von Andrian UH: Travellers in many guises: The origins and destinations of dendritic cells. Immunol Cell Biol 2002;80:448-462.
6. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: The multi-step paradigm. Cell 1994;76:301-314.
7. Ghosh S, Goldin E, Gordon FH, Malchow HA, Rask-Madsen J, Rutgeerts P et al: Natalizumab for active Crohn's disease. N Engl J Med 2003;348:24-32.
8. Miller DH, Khan OA, Sheremata WA, Blumhardt LD, Rice GP, Libonati MA et al: A controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 2003;348:15-23.
9. Kaech SM, Wherry EJ, Ahmed R: Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol 2002;2:251-262.
10. Pape KA, Kearney ER, Khoruts A, Mondino A, Merica R, Chen ZM et al: Use of adoptive transfer of T-cell-antigen-receptor-transgenic T cells for the study of T-cell activation in vivo. Immunol Rev 1997;156:67-78.
11. Reinhardt RL, Jenkins MK: Whole-body analysis of T-cell responses. Curr Opin Immunol 2003;15:366-371.
12. Menger MD, Lehr HA: Scope and perspectives of intravital microscopy - Bridge over from in vitro to in vivo. Immunol Today 1993;14:519-522.
13. Von Andrian UH: Intravital microscopy of the peripheral lymph node microcirculation in mice. Microcirculation 1996;3:287-300.
14. Manjunath N, Shankar P, Stockton B, Dubey PD, Lieberman J, von Andrian UH: A transgenic mouse model to analyze CD8(+) effector T-cell differentiation in vivo. Proc Natl Acad Sci USA 1999;96:13932-13937.
15. Singbartl K, Thatte J, Smith ML, Wethmar K, Day K, Ley K: A CD2-green fluorescence protein-transgenic mouse reveals very late antigen-4-dependent CD8(+)lymphocyte rolling in inflamed venules. J Immunol 2001;166:7520-7526.
16. Denk W, Strickler JH, Webb WW: Two-photon laser scanning fluorescence microscopy. Science 1990;248:73-76.
17. Williams RM, Zipfel WR, Webb WW: Multi-photon microscopy in biological research. Curr Opin Chem Biol 2001;5:603-608.
18. Michalet X, Kapanidis AN, Laurence T, Pinaud F, Doose S, Pflughoefft M et al: The power and prospects of fluorescence microscopies and spectroscopies. Annu Rev Biophys Biomol Struct 2003:161-182.
19. Cahalan MD, Parker I, Wei SH, Miller MJ: Two-photon tissue imaging: Seeing the immune system in a fresh light. Nat Rev Immunol 2002;2:872-880.
20. Von Andrian UH: Immunology. T-cell activation in six dimensions. Science 2002;296: 1815-1817.
21. Massoud TF, Gambhir SS: Molecular imaging in living subjects: Seeing fundamental biological processes in a new light. Genes Dev 2003;17:545-580.
22. Herschman HR: Micro-PET imaging and small animal models of disease. Curr Opin Immunol 2003;15:378-384.
23. Pautler RG, Fraser SE: The year(s) of the contrast agent - Micro-MRI in the new millennium. Curr Opin Immunol 2003;15:385-392.
24. Contag CH, Bachmann MH: Advances in in vivo bioluminescence imaging of gene expression. Annu Rev Biomed Eng 2002;4:235-260.
25. Edinger M, Cao YA, Hornig YS, Jenkins DE, Verneris MR, Bachmann MH et al: Advancing animal models of neoplasia through in vivo bioluminescence imaging. Eur J Cancer 2002;38:2128-2136.
26. Mandl S, Schimmelpfennig C, Edinger M, Negrin RS, Contag CH: Understanding immune cell trafficking patterns via in vivo bioluminescence imaging. J Cell Biochem Suppl 2002;39: 239-248.
27. Edinger M, Cao YA, Verneris MR, Bachmann MH, Contag CH, Negrin RS: Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. Blood 2003;101:640-648.
28. Costa GL, Sandora MR, Nakajima A, Nguyen EV, Taylor-Edwards C, Slavin AJ et al: Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T-cell delivery of the IL-12 p40 subunit. J Immunol 2001; 167:2379-2387.
29. Nakajima A, Seroogy CM, Sandora MR, Tarner IH, Costa GL, Taylor-Edwards C et al: Antigen-specific T-cell-mediated gene therapy in collagen-induced arthritis. J Clin Invest 2001;107:1293-1301.
30. Van der Merwe PA, Davis SJ: Molecular interactions mediating T-cell antigen recognition. Annu Rev Immunol 2003;21:659-684.
31. Altman JD, Moss PAH, Goulder JR, Barouch DH, McHeyzer-Williams MG, Bell JI et al: Phenotypic analysis of antigen-specific T lymphocytes. Science 1996;274:94-97.
32. + T cells. J Immunol Methods 2002;268:71-81.
33. Klenerman P, Cerundolo V, Dunbar PR: Tracking T cells with tetramers: New tales from new tools. Nat Rev Immunol 2002;2:263-272.
34. Skinner PJ, Daniels MA, Schmidt CS, Jameson SC, Haase AT: Cutting edge: In situ tetramer staining of antigen-specific T cells in tissues. J Immunol 2000;165:613-617.
35. Czerkinsky C, Andersson G, Ferrua B, Nordstrom I, Quiding M, Eriksson K et al: Detection of human cytokine-secreting cells in distinct anatomical compartments. Immunol Rev 1991;119:5-22.
36. Prussin C, Metcalfe DD: Detection of intracy-toplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. J Immunol Methods 1995;188:117-128.
37. Manz R, Assenmacher M, Pfluger E, Miltenyi S, Radbruch A: Analysis and sorting of live cells according to secreted molecules, relocated to a cell-surface affinity matrix. Proc Natl Acad Sci USA 1995;92:1921-1925.
38. Blattman JN, Antia R, Sourdive DJ, Wang X, Kaech SM, Murali-Krishna K et al: Estimating the precursor frequency of naive antigen-specific CD8 T cells. J Exp Med 2002;195:657-664.
39. Takagi J, Petre BM, Walz T, Springer TA: Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling. Cell 2002;110:599-611.
40. Takagi J, Springer TA: Integrin activation and structural rearrangement. Immunol Rev 2002; 186:141-163.
41. Picker LJ, Butcher EC: Physiological and molecular mechanisms of lymphocyte homing. Annu Rev Immunol 1992;10:561-591.
42. Mackay C: Homing of naive, memory and effector lymphocytes. Curr Opin Immunol 1993;5:423-427.
43. Von Andrian UH, Mempel TR: Homing and cellular traffic in lymph nodes. Nat Rev Immunol 2003;3:867-878.
44. Svensson M, Marsal J, Ericsson A, Carramolino L, Broden T, Marquez G et al: CCL25 mediates the localization of recently activated CD8αβ(+) lymphocytes to the small-intestinal mucosa. J Clin Invest 2002;110:1113-1121.
45. Girard JP, Springer TA: High endothelial venules: Specialized endothelium for lymphocyte migration. Immunol Today 1995;16:449-457.
46. Warnock RA, Askari S, Butcher EC, von Andrian UH: Molecular mechanisms of lymphocyte homing to peripheral lymph nodes. J Exp Med 1998;187:205-216.
47. Stein JV, Rot A, Luo Y, Narasimhaswamy M, Nakano H, Gunn MD et al: The CC chemokine thymus-derived chemotactic agent 4 (TCA-4, secondary lymphoid tissue chemokine, 6Ckine, exodus-2) triggers lymphocyte function-associated antigen 1-mediated arrest of rolling T lymphocytes in peripheral lymph node high endothelial venules. J Exp Med 2000;191:61-76.
48. Bargatze RF, Jutila MA, Butcher EC: Distinct roles of L-selectin and integrins c447 and LFA-1 in lymphocyte homing to Peyer's patch-HEV in situ: The multistep model confirmed and refined. Immunity 1995;3:99-108.
49. 7 integrins, and P-selectin in leukocyte rolling and adhesion in high endothelial venules of Peyer's patches. J Immunol 1998;161:2449-2456.
50. Warnock RA, Campbell JJ, Dorf ME, Matsuzawa A, McEvoy LM, Butcher EC: The role of chemokines in the microenvironmental control of T- versus B-cell arrest in Peyer's patch high endothelial venules. J Exp Med 2000;191:77-88.
51. Sassetti C, Tangemann K, Singer MS, Kershaw DB, Rosen SD: Identification of podocalyxin-like protein as a high endothelial venule ligand for L-selectin: Parallels to CD34. J Exp Med 1998;187:1965-1975.
52. Imai Y, Lasky LA, Rosen SD: Sulphation requirement for GlyCAM-1, an endothelial ligand for L-selectin. Nature 1993;361:555-557.
53. Baumhueter S, Singer MS, Henzel W, Hemmerich S, Renz M, Rosen SD et al: Binding of L-selectin to the vascular sialomucin, CD34. Science 1993;262:436-438.
54. Hemmerich S, Butcher EC, Rosen SD: Sulfation-dependent recognition of high endothelial venules-ligands by L-selectin and MECA 79. J Exp Med 1994;180:2219-2226.
55. Kansas GS: Selectins and their ligands: Current concepts and controversies. Blood 1996;88:3259-3287.
56. Lowe JB: Glycosylation in the control of selectin counter-receptor structure and function. Immunol Rev 2002;186:19-36.
57. Hemmerich S, Bistrup A, Singer MS, van Zante A, Lee JK, Tsay D et al: Sulfation of L-selectin ligands by an HEV-restricted sulfotransferase regulates lymphocyte homing to lymph nodes. Immunity 2001;15:237-247.
58. Stockton BM, Cheng G, Manjunath N, Ardman B, von Andrian UH: Negative regulation of T-cell homing by CD43. Immunity 1998;8:373-381.
59. Baekkevold ES, Yamanaka T, Palframan RT, Carlsen HS, Reinholt FP, von Andrian UH et al: The CCR7 ligand ELC (CCL19) is transcytosed in high endothelial venules and mediates T-cell recruitment. J Exp Med 2001;193:1105-1112.
60. Nakano H, Tamura T, Yoshimoto T, Yagita H, Miyasaka M, Butcher EC et al: Genetic defect in T-lymphocyte-specific homing into peripheral lymph nodes. Eur J Immunol 1997;27:215-221.
61. Nakano H, Mori S, Yonekawa H, Nariuchi H, Matsuzawa A, Kakiuchi T: A novel mutant gene involved in T-lymphocyte-specific homing into peripheral lymphoid organs on mouse chromosome 4. Blood 1998;91:2886-2895.
62. Vassileva G, Soto H, Zlotnik A, Nakano H, Kakiuchi T, Hedrick JA et al: The reduced expression of 6Ckine in the plt mouse results from the deletion of one of two 6Ckine genes. J Exp Med 1999;190:1183-1188.
63. Luther SA, Tang HL, Hyman PL, Farr AG, Cyster JG: Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. Proc Natl Acad Sci USA 2000;97:12694-12699.
64. Nakano H, Gunn MD: Gene duplications at the chemokine locus on mouse chromosome 4: Multiple strain-specific haplotypes and the deletion of secondary lymphoid-organ chemokine and EBI-1 ligand chemokine genes in the plt mutation. J Immunol 2001;166:361-369.
65. Forster R, Schubel A, Breitfeld D, Kremmer E, Renner-Muller I, Wolf E et al: CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999;99:23-33.
66. Okada T, Ngo VN, Ekland EH, Forster R, Lipp M, Littman DR et al: Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J Exp Med 2002;196:65-75.
67. Johnson-Leger CA, Aurrand-Lions M, Beltraminelli N, Fasel N, Imhof BA: Junctional adhesion molecule-2 (JAM-2) promotes lymphocyte transendothelial migration. Blood 2002;100:2479-2486.
68. Ostermann G, Weber KS, Zernecke A, Schroder A, Weber C: JAM-1 is a ligand of the β2 integrin LFA-1 involved in transendothelial migration of leukocytes. Nat Immunol 2002;3:151-158.
69. Brandtzaeg P, Baekkevold ES, Farstad IN, Jahnsen FL, Johansen FE, Nilsen EM et al: Regional specialization in the mucosal immune system: What happens in the microcompartments? Immunol Today 1999;20:141-151.
70. Berg EL, McEvoy LM, Berlin C, Bargatze RF, Butcher EC: L-selectin-mediated lymphocyte rolling on MAdCAM-1. Nature 1993;366:695-698.
71. Nolte MA, Hamann A, Kraal G, Mebius RE: The strict regulation of lymphocyte migration to splenic white pulp does not involve common homing receptors. Immunology 2002;106:299-307.
72. Cyster JG, Goodnow CC: Pertussis toxin inhibits migration of B and T lymphocytes into splenic white pulp cords. J Exp Med 1995;182:581-586.
73. Xu B, Wagner N, Pham LN, Magno V, Shan Z, Butcher EC et al: Lymphocyte homing to bronchus-associated lymphoid tissue is mediated by L-selectin/PNAd, α4β1 integrin/VCAM-1 and LFA-1 adhesion pathways. J Exp Med 2003;197:1255-1267.
74. Von Andrian UH, Chambers JD, McEvoy LM, Bargatze RF, Arfors KE, Butcher EC: Two-step model of leukocyte-endothelial cell interaction in inflammation: Distinct roles for LECAM-1 and the leukocyte β2 integrins in vivo. Proc Natl Acad Sci USA 1991;88:7538-7542.
75. Ley K, Gaehtgens P, Fennie C, Singer MS, La-sky LA, Rosen SD: Lectin-like cell adhesion molecule-1 mediates leukocyte rolling in mesenteric venules in vivo. Blood 1991;77:2553-2555.
76. Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA: A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med 1996;184:1101-1110.
77. + T-cell accumulation in rheumatoid arthritis synovium. J Immunol 2000;165:6590-6598.
78. Buckley CD, Amft N, Bradfield PF, Pilling D, Ross E, Arenzana-Seisdedos F et al: Persistent induction of the chemokine receptor CXCR4 by TGF-β1 on synovial T cells contributes to their accumulation within the rheumatoid synovium. J Immunol 2000;165:3423-3429.
79. Campbell JJ, Hedrick J, Zlotnik A, Siani MA, Thompson DA, Butcher EC: Chemokines and the arrest of lymphoyctes rolling under flow conditions. Science 1998;279:381-384.
80. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA: Induction by IL-1 and inter-feron, tissue distribution, biochemistry and function of a natural adherence molecule (ICAM-1). J Immunol 1986;137:245-254.
81. + T cells. Immunol Rev 2002;185:221-233.
82. Weninger W, Carlsen HS, Goodarzi M, Moazed F, Crowley MA, Baekkevold ES et al: Naïve T-cell recruitment to non-lymphoid tissues: A role for endothelium-expressed CCL21 in autoimmune disease and lymphoid neogenesis. J Immunol 2003;170:4638-4648.
83. Gunn MD, Tangemann K, Tam C, Cyster JG, Rosen SD, Williams LT: A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc Natl Acad Sci USA 1998;95:258-263.
84. Hjelmstrom P: Lymphoid neogenesis: De novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. J Leukoc Biol 2001;69:331-339.
85. Grant AJ, Goddard S, Ahmed-Choudhury J, Reynolds G, Jackson DG, Briskin M et al: Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease. Am J Pathol 2002; 160:1445-1455.
86. Alt C, Laschinger M, Engelhardt B: Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis. Eur J Immunol 2002;32:2133-2144.
87. Christophers E, Mrowietz U: Psoriasis; in Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI (eds): Dermatology in General Medicine. New York, McGraw-Hill, 1998, pp 495-521.
88. Fan L, Reilly CR, Luo Y, Dorf ME, Lo D: Cutting edge: Ectopic expression of the chemokine TCA4/SLC is sufficient to trigger lymphoid neogenesis. J Immunol 2000;164:3955-3959.
89. Chen SC, Vassileva G, Kinsley D, Holzmann S, Manfra D, Wiekowski MT et al: Ectopic expression of the murine chemokines CCL21a and CCL21b induces the formation of lymph node-like structures in pancreas, but not skin, of transgenic mice. J Immunol 2002;168:1001-1008.
90. Luther SA, Bidgol A, Hargreaves DC, Schmidt A, Xu Y, Paniyadi J et al: Differing activities of homeostatic chemokines CCL19, CCL21 and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J Immunol 2002;169:424-433.
91. Schrama D, thor Straten P, Fischer WH, McLellan AD, Brocker EB, Reisfeld RA et al: Targeting of lymphotoxin α to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue. Immunity 2001;14:111-121.
92. + T cells are a major source of lymphotoxin α. J Immunol 1999;162:3790-3794.
93. Gramaglia I, Mauri DN, Miner KT, Ware CF, Croft M: Lymphotoxin α/β is expressed on recently activated naive and Th1-like CD4 cells but is down-regulated by IL-4 during Th2 differentiation. J Immunol 1999;162:1333-1338.
94. Mebius RE: Organogenesis of lymphoid tissues. Nat Rev Immunol 2003;3:292-303.
95. Ngo VN, Korner H, Gunn MD, Schmidt KN, Riminton DS, Cooper MD et al: Lymphotoxin α/β and tumor necrosis factor are required for stromal cell expression of homing chemokines in B- and T-cell areas of the spleen. J Exp Med 1999;189:403-412.
96. Kratz A, Campos-Neto A, Hanson MS, Ruddle NH: Chronic inflammation caused by lymphotoxin is lymphoid neogenesis. J Exp Med 1996;183:1461-1472.
97. Miller MJ, Wei SH, Parker I, Cahalan MD: Two-photon imaging of lymphocyte motility and antigen response in intact lymph node. Science 2002;296:1869-1873.
98. Miller MJ, Wei SH, Cahalan MD, Parker I: Autonomous T-cell trafficking examined in vivo with intravital two-photon microscopy. Proc Natl Acad Sci USA 2003;100:2604-2609.
99. Bousso P, Robey E: Dynamics of CD8(+) Tcell priming by dendritic cells in intact lymph nodes. Nat Immunol 2003;4:579-585.
100. Stoll S, Delon J, Brotz TM, Germain RN: Dynamic imaging of T-cell-dendritic cell interactions in lymph nodes. Science 2002;296:1873-1876.
101. D'Ambrosio D, Iellem A, Colantonio L, Clissi B, Pardi R, Sinigaglia F: Localization of Th-cell subsets in inflammation: Differential thresholds for extravasation of Th1 and Th2 cells. Immunol Today 2000;21:183-186.
102. Kim CH, Broxmeyer HE: Chemokines: Signal lamps for trafficking of T and B cells for development and effector function. J Leukoc Biol 1999;65:6-15.
103. Sallusto F, Mackay CR, Lanzavecchia A: The role of chemokine receptors in primary, effector and memory immune responses. Annu Rev Immunol 2000;18:593-620.
104. Austrup F, Vestweber D, Borges E, Lohning M, Brauer R, Herz U et al: P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues. Nature 1997;385:81-83.
105. Wagers AJ, Waters CM, Stoolman LM, Kansas GS: Interleukin-12 and interleukin-4 control T-cell adhesion to endothelial selectins through opposite effects on α1, 3-fucosyltransferase VII gene expression. J Exp Med 1998;188:2225-2231.
106. Lim YC, Henault L, Wagers AJ, Kansas GS, Luscinskas FW, Lichtman AH: Expression of functional selectin ligands on Th cells is differentially regulated by IL-12 and IL-4. J Immunol 1999;162:3193-3201.
107. Smithson G, Rogers CE, Smith PL, Scheideg-ger EP, Petryniak B, Myers JT et al: Fuc-TVII is required for T-helper 1 and T-cytotoxic 1 lymphocyte selectin ligand expression and recruitment in inflammation, and together with Fuc-TIV regulates naive T-cell trafficking to lymph nodes. J Exp Med 2001;194:601-614.
108. Sako D, Chang XJ, Barone KM, Vachino G, White HM, Shaw G et al: Expression cloning of a functional glycoprotein ligand for P-selectin. Cell 1993;75:1179-1186.
109. Borges E, Tietz W, Steegmaier M, Moll T, Hallmann R, Hamann A et al: P-selectin glycoprotein ligand-1 (PSGL-1) on T-helper 1 but not on T-helper 2 cells binds to P-selectin and supports migration into inflamed skin. J Exp Med 1997;185:573-578.
110. Hirata T, Merrill-Skoloff G, Aab M, Yang J, Furie BC, Furie B: P-selectin glycoprotein ligand 1 is a physiological ligand for E-selectin in mediating T-helper 1 lymphocyte migration. J Exp Med 2000;192:1669-1676.
111. Steegmaier M, Levinovitz A, Isenmann S, Borges E, Lenter M, Kocher HP et al: The E-selectin-ligand ESL-1 is a variant of a receptor for fibroblast growth factor. Nature 1995;373:615-620.
112. White SJ, Underhill GH, Kaplan MH, Kansas GS: Cutting edge: Differential requirements for Stat4 in expression of glycosyltransferases responsible for selectin ligand formation in Th1 cells. J Immunol 2001;167:628-631.
113. Lim YC, Xie H, Come CE, Alexander SI, Grusby MJ, Lichtman AH et al: IL-12, STAT4-dependent up-regulation of CD4(+) T-cell core 2β-1,6-n- acetylglucosaminyltrans-ferase, an enzyme essential for biosynthesis of P-selectin ligands. J Immunol 2001;167: 4476-4484.
114. + T cells migrate into inflamed skin only if they express ligands for E- and P-selectin. J Immunol 1998;161:963-970.
115. Xie H, Lim YC, Luscinskas FW, Lichtman AH: Acquisition of selectin binding and peripheral homing properties by CD4(+) and CD8(+) T cells. J Exp Med 1999;189:1765-1776.
116. Lee SH, Prince JE, Rais M, Kheradmand F, Shardonofsky F, Lu H et al: Differential requirement for CD18 in T-helper effector homing. Nat Med 2003;9:1281-1286.
117. + (memory) but not CD45RA+RO(-)(naive) T cells roll efficiently on E- and P-selectin and vascular cell adhesion molecule-1 under flow. J Immunol 1997; 158:3640-3650.
118. Sallusto F, Kremmer E, Palermo B, Hoy A, Ponath P, Qin S et al: Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells. Eur J Immunol 1999;29: 2037-2045.
119. Campbell DJ, Butcher EC: Rapid acquisition of tissue-specific homing phenotypes by CD4(+) T cells activated in cutaneous or mucosal lymphoid tissues. J Exp Med 2002;195: 135-141.
120. Kim CH, Rott L, Kunkel EJ, Genovese MC, Andrew DP, Wu L et al: Rules of chemokine receptor association with T-cell polarization in vivo. J Clin Invest 2001;108:1331-1339.
121. + T cells. J Leukoc Biol 2000;68:568-574.
122. Nanki T, Lipsky PE: Lack of correlation between chemokine receptor and T(h)1/T(h)2 cytokine expression by individual memory T cells. Int Immunol 2000;12:1659-1667.
123. Picker LJ, Terstappen LWMM, Rott LS, Streeter PR, Stein H, Butcher EC: Differential expression of homing-associated adhesion molecules by T-cell subsets in man. J Immunol 1990;145:3247-3255.
124. Picker LJ: Control of lymphocyte homing. Curr Opin Immunol 1994;6:394-406.
125. Fuhlbrigge RC, Kieffer JD, Armerding D, Kupper TS: Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells. Nature 1997;389:978-981.
126. Robert C, Kupper TS: Inflammatory skin diseases, T cells, and immune surveillance. N Engl J Med 1999;341:1817-1828.
127. Picker LJ, Michie SA, Rott LS, Butcher EC: A unique phenotype of skin-associated lymphocytes in humans: Preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites. Am J Pathol 1990;136:1053-1068.
128. Picker LJ, Treer JR, Fergusen-Darnell B, Collins PA, Bergstresser PR, Terstappen LWMM: Control of lymphocyte recirculation in man. II. Differential regulation of the cutaneous lymphocyte-associated antigen, a tissue-selective homing receptor for skin-homing T cells. J Immunol 1993;150:1122-1136.
129. Santamaria Babi LF, Picker LJ, Perez Soler MT, Drzimalla K, Flohr P, Blaser K et al: Circulating allergen-reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen. J Exp Med 1995;181:1935-1940.
130. Koelle DM, Liu Z, McClurkan CM, Topp MS, Riddell SR, Pamer EG et al: Expression of cutaneous lymphocyte-associated antigen by CD8(+) T cells specific for a skin-tropic virus. J Clin Invest 2002;110:537-548.
131. Bevilacqua MP, Stengelin S, Gimbrone MA, Seed B: Endothelial leukocyte adhesion molecule 1: An inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 1989;243:1160-1165.
132. Berg EL, Yoshino T, Rott LS, Robinson MK, Warnock RA, Kishimoto TK et al: The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1. J Exp Med 1991;174:1461-1466.
133. Picker LJ, Kishimoto TK, Smith CW, War-nock RA, Butcher EC: ELAM-1 is an adhesion molecule for skin-homing T cells. Nature 1991;349:796-798.
134. Weninger W, Ulfman LH, Cheng G, Souchkova N, Quackenbush EJ, Lowe JB et al: Specialized contributions by α(1,3)-fucosyltransferase-IV and FucT-VII during leukocyte rolling in dermal microvessels. Immunity 2000; 12:665-676.
135. Mazo IB, Gutierrez-Ramos JC, Frenette PS, Hynes RO, Wagner DD, von Andrian UH: Hematopoietic progenitor cell rolling in bone marrow microvessels: Parallel contributions by endothelial selectins and VCAM-1. J Exp Med 1998;188:465-474.
136. Campbell J, Haraldsen G, Pan J, Rottman J, Qin S, Ponath P et al: The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 1999;400:776-780.
137. Homey B, Alenius H, Muller A, Soto H, Bowman EP, Yuan W et al: CCL27-CCR10 interactions regulate T-cell-mediated skin inflammation. Nat Med 2002;8:157-165.
138. Hudak S, Hagen M, Liu Y, Catron D, Oldham E, McEvoy LM et al: Immune surveillance and effector functions of CCR10(+) skin homing T cells. J Immunol 2002;169: 1189-1196.
139. Soler D, Humphreys TL, Spinola SM, Campbell JJ: CCR4 versus CCR10 in human cutaneous TH lymphocyte trafficking. Blood 2003;101:1677-1682.
140. Ferenczi K, Fuhlbrigge RC, Pinkus J, Pinkus GS, Kupper TS: Increased CCR4 expression in cutaneous T-cell lymphoma. J Invest Dermatol 2002;119:1405-1410.
141. Morales J, Homey B, Vicari AP, Hudak S, Oldham E, Hedrick J et al: CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proc Natl Acad Sci USA 1999;96:14470-14475.
142. Reiss Y, Proudfoot AE, Power CA, Campbell JJ, Butcher EC: CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T-cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J Exp Med 2001;194:1541-1547.
143. + cells with memory for intestinal rotavirus. J Clin Invest 1997;100:1204-1208.
144. + memory T cells to clear rotavirus infection. J Virol 1998;72:726-730.
145. Hamann A, Andrew DP, Jablonski-Westrich D, Holzmann B, Butcher EC: Role of α4-integrins in lymphocyte homing to mucosal tissues in vivo. J Immunol 1994;152:3282-3293.
146. + T-cell-mediated intestinal immunity to rotavirus. J Clin Invest 2000; 106:1541-1552.
147. Haddad W, Cooper CJ, Zhang Z, Brown JB, Zhu Y, Issekutz A et al: P-selectin and P-selectin glycoprotein ligand 1 are major determinants for Th1 cell recruitment to nonlym-phoid effector sites in the intestinal lamina propria. J Exp Med 2003;198:369-377.
148. Zabel BA, Agace WW, Campbell JJ, Heath HM, Parent D, Roberts AI et al: Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis. J Exp Med 1999;190:1241-1256.
149. Kunkel EJ, Campbell JJ, Haraldsen G, Pan J, Boisvert J, Roberts AI et al: Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific che-mokines as an organizing principle in regional immunity. J Exp Med 2000;192:761-768.
150. Papadakis KA, Prehn J, Nelson V, Cheng L, Binder SW, Ponath PD et al: The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune system. J Immunol 2000;165:5069-5076.
151. Johansson-Lindbom B, Svensson M, Wurbel MA, Malissen B, Marquez G, Agace W: Selective generation of gut tropic T cells in gut-associated lymphoid tissue: Requirement for GALT dendritic cells and adjuvant. J Exp Med 2003;198:963-969.
152. Westermann J, Pabst R: How organ-specific is the migration of 'naive' and 'memory' T cells? Immunol Today 1996;17:278-282.
153. Kantele A, Kantele JM, Savilahti E, Westerholm M, Arvilommi H, Lazarovits A et al: Homing potentials of circulating lymphocytes in humans depend on the site of activation: Oral, but not parenteral, typhoid vaccination induces circulating antibody-secreting cells that all bear homing receptors directing them to the gut. J Immunol 1997;158:574-579.
154. Davenport MP, Grimm MC, Lloyd AR: A homing selection hypothesis for T-cell trafficking. Immunol Today 2000;21:315-317.
155. Reinhardt RL, Khoruts A, Merica R, Zell T, Jenkins MK: Visualizing the generation of memory CD4 T cells in the whole body. Nature 2001;410:101-105.
156. Reinhardt RL, Bullard DC, Weaver CT, Jenkins MK: Preferential accumulation of antigen-specific effector CD4 T cells at an antigen injection site involves CD62E-dependent migration but not local proliferation. J Exp Med 2003;197:751-762.
157. Stagg AJ, Kamm MA, Knight SC: Intestinal dendritic cells increase T-cell expression of α4β7 integrin. Eur J Immunol 2002;32:1445-1454.
158. Mora JR, Bono MR, Manjunath N, Weninger W, Cavanagh LL, Rosemblatt M et al: Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 2003;424:88-93.
159. Mowat AM: Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol 2003;3:331-341.